Cite

    Chiara Vendramin et al.. “A single‐center prospective study on the safety of plasma exchange procedures using a double‐viral‐inactivated and prion‐reduced solvent/detergent fresh‐frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy.” Transfusion, vol. 57, no. 1, 2017, pp. 131–136. http://access.bl.uk/ark:/81055/vdc_100040921796.0x00004c